Across 100 patients in three Phase III studies, Casgevy showed lasting benefits....
Vertex, Inc. (NASDAQ:VERX - Get Free Report) has been given an average recommendation of "Moderate B...
Vertex Pharmaceuticals (VRTX) said Thursday that longer term data from ongoing clinical trials show...
Palisade Capital Management LP trimmed its stake in shares of Vertex, Inc. (NASDAQ:VERX - Free Repor...